Literature DB >> 7130853

Bile acids and lipids in isolated rat hepatocytes: content, synthesis, and release, as affected by cholestyramine treatment of the donor rats.

H J Kempen, M P Vos-Van Holstein, J de Lange.   

Abstract

Contents of bile acids and lipids, as well as rates of triglyceride synthesis, were determined in isolated hepatocytes from control or cholestyramine-fed rats (denoted below as "control" or "treated" hepatocytes, respectively). During a 3-hr incubation period, total bile acid production was markedly higher in "treated" cells than in "control" cells. With both kinds of cells a marked fall in production rate occurred after the first hour of incubation. Newly produced bile acids appeared in the conjugated form with both kinds of hepatocytes. "Control" cells produced only taurine-conjugated, while "treated" cells made both taurine-conjugated and glycine-conjugated bile acids. However, with exogenous taurine (0.5 mM), the latter cells also produced taurine-conjugated bile acids only. With both kinds of cells, cholic and beta-muricholic acids, but not dihydroxylated bile acids, appeared as newly formed species during the incubation. Addition of dialyzed rat serum to the incubation did not result in a stimulation of bile acid production, with either kind of hepatocytes. "Treated" cells had a slightly higher content of free cholesterol than control cells; contents of other lipids were not different. Fractional release of bile acids and lipids into the medium did not differ between the two kinds of cells. Triglyceride synthesis from added [14C]palmitate (0.5 mM) was 1.8-fold higher in "treated" than in "control" hepatocytes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7130853

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  8 in total

1.  Heterogeneity of rat liver parenchyma in cholesterol 7 alpha-hydroxylase and bile acid synthesis.

Authors:  B Ugele; H J Kempen; J M Kempen; R Gebhardt; P Meijer; H J Burger; H M Princen
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Cyclosporin A blocks bile acid synthesis in cultured hepatocytes by specific inhibition of chenodeoxycholic acid synthesis.

Authors:  H M Princen; P Meijer; B G Wolthers; R J Vonk; F Kuipers
Journal:  Biochem J       Date:  1991-04-15       Impact factor: 3.857

3.  Ketoconazole blocks bile acid synthesis in hepatocyte monolayer cultures and in vivo in rat by inhibiting cholesterol 7 alpha-hydroxylase.

Authors:  H M Princen; C M Huijsmans; F Kuipers; R J Vonk; H J Kempen
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

4.  Effect of chylomicron remnants on cholesterol metabolism in cultured rabbit hepatocytes: very low density lipoprotein and bile acid production.

Authors:  V A Kosykh; D K Novikov; I N Trakht; E A Podrez; A V Victorov; V S Repin; V N Smirnov
Journal:  Lipids       Date:  1991-10       Impact factor: 1.880

5.  Concomitant increase in hepatic triacylglycerol biosynthesis and cytosolic fatty-acid-binding-protein content after feeding rats with a cholestyramine-containing diet.

Authors:  H J Kempen; J F Glatz; J de Lange; J H Veerkamp
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

6.  Bile acid and very low density lipoprotein production by cultured hepatocytes from hypo- or hyperresponsive rabbits fed cholesterol.

Authors:  E A Podrez; V A Kosykh; Y V Lakeev; E I Kosenkov; E T Mambetisaeva; V S Repin; V N Smirnov; T A Miettinen
Journal:  Lipids       Date:  1993-08       Impact factor: 1.880

7.  Differential binding of glycine- and taurine-conjugated bile acids to insoluble calcium phosphate.

Authors:  R Van der Meer; H T De Vries
Journal:  Biochem J       Date:  1985-07-01       Impact factor: 3.857

8.  Heterogeneous expression of cholesterol 7 alpha-hydroxylase and sterol 27-hydroxylase genes in the rat liver lobulus.

Authors:  J Twisk; M F Hoekman; W H Mager; A F Moorman; P A de Boer; L Scheja; H M Princen; R Gebhardt
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.